Dental Care in Patients with Myasthenia Gravis
Authors:
J. Piťha
Authors place of work:
Centrum myasthenia gravis, Praha
; Neurologická klinika 1. LF UK a VFN, Praha
Published in the journal:
Česká stomatologie / Praktické zubní lékařství, ročník 110, 2010, 2, s. 26-31
Category:
Summary
Myasthenia gravis is an autoimmune disease in the neuromuscular transmission, causing muscular weakness and fatique especially in the facial and pharyngeal muscles. The stomatology care provided to these patients should consider specificities of this disease. Some patients are afflicted by from residual disorders of muscles in the oral cavity, and others suffer from side effects of drugs which inhibit autoimmune inflammation. Various drugs can even deteriorate symptoms of the disease. Anesthesiology should also acquire specific approaches. Stomatologists should be aware of all risks associated with taking care of these patients, but their approach to the patients should not be accompanied by useless worries.
Key words:
myasthenia gravis - stomatology care - oropharyngeal weakness - drug intolerance - anaesthesia
Zdroje
1. Bahn, S. L.: Glucococrticoids in dentistry. J. Am. Dent. Assoc., roč. 105, 1982, č. 3, s. 476-481.
2. Bassler, R.: Histopathology of different types of atrophy of the human tongue. Path. Res. Pract., roč. 182, 1987, č. 1, s. 87-89.
3. Bottomley, W. K., Terezhalmy, G. T.: Mangement of patients with myasthenia gravis who require maxillary dentures. J. J. Prosthget. Dent., roč. 38, 1977, č. 6, s. 609-614.
4. Burch, J., Waren-Gash, C., Ingham, V., Patel, M., Bennett, D., Chaudhuri, K. R.: Myasthenia gravis - a rare presentation with tongue atrophy and fasciculation. Age Ageing, roč. 35, 2006, č. 1, s. 87-88.
5. Butler, R. T., Kalwarf, K. L., Kaldahl, W. B.: Drug-induced gingival hyperplasia: phenytoin, cyclosporine and nifedipine. J. Am. Dent. Assoc., roč. 114, 1987, č. 1, s. 56-60.
6. Calcaterra, T. C., Stern, F., Herman, C. Jr., Mudler, D. G.: The otolarylgologist´s role in myasthenia gravis. Trans. Am. Ac. Optal. Otolaryngol., roč. 72, 1972, č. 2, s. 308-312.
7. Carpanter, R. J., Macdonald, T. J., Howard, F. M. Jr.: The otolaryngoligic presentation of myasthenia gravis. Laryngoscope, roč. 89, 1979, č. 6, s. 992-998.
8. Colton-Hudson, A., Koopman, W. J., Moosa, T., Smith, D., Bach, D., Nicolle, M.: A prospective assessment of the characteristics of dysphagia in myasthenia gravis. Dysphagia, roč. 17, 2002, č. 2, s. 147-151.
9. Davison, S. P., Macdonald, T. J., Wolfe, M. E.: Swollen tongue: a presentation of myasthenia gravis. Otolaryngol Head Neck Surg., roč. 116, 1997, č. 2, s. 224-226.
10. Dhillon, R. S., Brookes, G. B.: Myasthenia gravis in otolaryngologiocal practice. Clin. Otolaryngol Allen. Sci., roč. 9, 1984, č. 1, s. 27-34.
11. Dillon, F. X.: Anesthesia issues in the perioperative management of children with myasthenia gravis. J. Dent. Children, roč. 45, 1978, č. 2, s. 47-50.
12. Farrugia, M. E., Rondon, M. D., Clover, L., Anslow, P., Newsom-Davis, J., Kennett, R., Hilton-Jones, D., Matthews, P. M., Vincent, A.: MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain, roč. 129, 2006, č. 6, s. 1481-1492.
13. Howard, J. F. Jr.: Adverse drug interactions in disorders of neuromuscular transmission. J. Neurol. Orthop. Med. Surg., roč. 12, 1991, č. 3, s. 26-34.
14. Kernstine, K. H.: Preoperative preparation of the patient with myasthenia gravis. Thorac Surg. Clin., roč. 15, 2005, č. 2, s. 287-296.
15. Klein, K. J., Bromberg, M. B., Feldman, E. L., Simmons, Z.: Dysphagia in elderly men with myasthenia gravis. J. Neurol. Sci., roč. 138, 1996, č. 1-2, s. 49-52.
16. Llabres, M., Molina-Martinez, F. J., Mirrales, F.: Dysphafia at sole manifestation of myasthenia gravis. J. Neurol. Neurosurg. Psychiatry, roč. 79, 2005, č. 9, s. 1297-1300.
17. Mason, D. K.: Oral aspects of myasthenia gravis. Dent. Practic., roč. 15, 1964, č. 2, s. 23-25.
18. Miller, C. S., Little, J. W., Falace, D. A.: Supplemental corticosteroids for dental patients with adrenal insufficiency: reconsideration of the problem. J. Am. Dent. Assoc., roč. 132, 2001, č. 11, s. 1570-1579.
19. Norman, E. L.: Myasthenia gravis: a nursing perspective. J. Neurosci. Nurs, roč. 18, 1986, č. 2, s. 74-80.
20. Patron, L. L., Howarrd, Jr. J. F.: Myasthenia gravis: dental treatment considerations. Spec. Care Dent., roč. 17, 1997, č. 1, s. 25-32.
21. Sanders, D. B., Howard, Jr. J. F., Johns, T. R., Campa, J. F.: High-dose daily prednisone in treatment of myasthenia gravis. In: Plasmapheresis and the Immunobiology of Myasthenia Gravis. Ed Dau PC. Boston, Houghton-Mifflin Publishers, 1979, s. 289-306.
22. Sasakura, Y., Kumasaka, S., Takahashi, T., Shindo, J.:Myasthenia gravis associated with reduced masticatory function. Int. J. Oral. Maxillofac. Surg., roč. 29, 2000, č. 5, s. 381-383.
23. Sabate, N. W., Seymour, G. J., Robinson, M. F.: Cyclosporin-A – inducend gingival enlargement. A case report. J. Periodontol, roč. 58, 1987, č. 7, s. 475-480.
24. Scherer, K., Bedlack, R. S., Simel, D. L.: Does this patient have myasthenia gravis? JAMA, roč. 293, 2005, č. 15, s. 1906-1914.
25. Schneider, P. E.: Dental management of a child with severe myasthenia gravis. Spec. Care Dent., roč. 3, 1993, č. 3, s. 266-270.
26. Seymour, R. A., Thomason, J. M., Ellis, J. S.: The pathogenesis of drug-induced gingival overgrowth. J. Clin. Periodontol, roč. 23, 1996, č. 3, s. 165-175.
27. Shaw, D. H., Cohen, D. M., Hoffman, M.: Dental treatment of patients with myasthenia gravis. J. Oral. Med., roč. 37, 1982, č. 4, s. 118-120.
28. Spicer, G. H.: Dental clues to myasthenia gravis. Dental Survey, roč. 41, 1965, č.4, 56-58.
29. Van der Blit, A., Weijnen, F. G., Bosman, F., van der Glas, H. W., Kuks, J. B. M.: Conroled study od EMG activity of jaw closers and openers masticationin patients with myasthenia gravis. Eur. J. Oral. Sci., roč. 109, 2001, č. 3, s. 60-164.
30. Weijnen, F. G., van der Blit, A., Kuks, J. B., van der Glas, H. W., Oudenaarde, I., Bosman, F.: Masticatory performance in patients with myasthenia gravis. Arch. Oral. Biol, roč. 47, 2002, č. 5, s. 393-398.
31. Weijnen, F. G., van der Blit, A., Sokle, J. H. J., Eassenberg, M. W. M., Oudenaarde, I.: Oral funkcions of patients with myasthenia gravis. Ann. NY Acad. Sci., roč. 41, 1998, č. 5, s. 773-776.
32. Yarom, N., Bornea, E., Nissan, J., Gorsky, M.: Dental management of patients with myasthenia gravis: a literature rewiew. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod., roč. 100, 2005, č. 2, s. 158-163.
Štítky
Maxillofacial surgery Orthodontics Dental medicineČlánok vyšiel v časopise
Czech Dental Journal
2010 Číslo 2
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- Bone Piezosurgery in Oral and Maxillofacial Region
- Sequelae of Dental Trauma in the Primary Dentition
- Dental Care in Patients with Myasthenia Gravis
- Orthodontic Therapy in Patient with Facial Complete Palate Cleft (Part 2)